John Wiley & Sons
Enzymes and Drugs
Product Code:
9781786309396
ISBN13:
9781786309396
Condition:
New
$165.00
$159.77
Sale 3%
Enzyme dysfunction, an essential catalyst for the smooth running of biochemical reactions and the maintenance of vital processes, is at the root of many pathologies that have paved the way for the development of numerous drugs. Aimed at pharmacists, biologists, biochemists, doctors, veterinarians, medicinal chemists and students from a wide range of disciplines, Enzymes and Drugs brings together, for the first time, extensive documentation highlighting the relationships between a large number of drugs and enzymes. The book also highlights new prospects for therapeutic discoveries offered by enzyme targeting. Numerous applications have been developed thanks to strategies for studying enzyme inhibition or activation, as well as the development of allosteric effectors, presented with their advantages and disadvantages. Various rare diseases, known as "orphan" diseases, have resulted from enzyme deficiency or absence. For their treatment, the introduction of substitute enzymes has led to major therapeutic advances.
| Author: Serge Kirkiacharian, Julien Dumond |
| Publisher: John Wiley & Sons |
| Publication Date: Jul 03, 2024 |
| Number of Pages: 228 pages |
| Language: English |
| Binding: Hardcover |
| ISBN-10: 1786309394 |
| ISBN-13: 9781786309396 |
Enzymes and Drugs
$165.00
$159.77
Sale 3%
Enzyme dysfunction, an essential catalyst for the smooth running of biochemical reactions and the maintenance of vital processes, is at the root of many pathologies that have paved the way for the development of numerous drugs. Aimed at pharmacists, biologists, biochemists, doctors, veterinarians, medicinal chemists and students from a wide range of disciplines, Enzymes and Drugs brings together, for the first time, extensive documentation highlighting the relationships between a large number of drugs and enzymes. The book also highlights new prospects for therapeutic discoveries offered by enzyme targeting. Numerous applications have been developed thanks to strategies for studying enzyme inhibition or activation, as well as the development of allosteric effectors, presented with their advantages and disadvantages. Various rare diseases, known as "orphan" diseases, have resulted from enzyme deficiency or absence. For their treatment, the introduction of substitute enzymes has led to major therapeutic advances.
| Author: Serge Kirkiacharian, Julien Dumond |
| Publisher: John Wiley & Sons |
| Publication Date: Jul 03, 2024 |
| Number of Pages: 228 pages |
| Language: English |
| Binding: Hardcover |
| ISBN-10: 1786309394 |
| ISBN-13: 9781786309396 |
Related Products
Sale 7%
Jenny Stanford Publishing
Pharmaceutical Biocatalysis : Fundamentals, Enzyme Inhibitors, and Enzymes in Health and Diseases
$515.90
Sale 6%
